RotaTeq Vaccine is an oral live-attenuated vaccine designed to protect infants against rotavirus gastroenteritis, a common cause of severe diarrhea in young children. It helps build immunity and reduce the risk of hospitalization from rotavirus infection.

Key Features:

• Oral live-attenuated pentavalent rotavirus vaccine.
• Each 2ml dose contains five strains of rotavirus for broad protection.
• Reduces the risk and severity of rotavirus-induced diarrhea.
• Administered orally to infants as part of the recommended vaccination schedule.
• Helps prevent dehydration and hospitalization related to rotavirus infection.
• Suitable for infants from 6 weeks of age as directed by a healthcare professional.

Recommended Usage:
Administer orally according to the infant immunization schedule, usually in a three-dose series at 2, 4, and 6 months of age. Store refrigerated at 2–8°C and do not freeze. Use under the guidance of a qualified healthcare provider.